Nonmyeloablative Allogeneic Stem Cell Transplantation for Chronic Myelogenous Leukemia in the Imatinib Era-Reference-Cited by-同舟云学术

Nonmyeloablative Allogeneic Stem Cell Transplantation for Chronic Myelogenous Leukemia in the Imatinib Era

Published:2009-09 Issue: Volume:9 Page:S261-S265
ISSN:1557-9190
Container-title:Clinical Lymphoma and Myeloma
language:en
Short-container-title:Clinical Lymphoma and Myeloma

Author:

Champlin Richard,de Lima Marcos,Kebriaei Partow,Rondon Gabriela,Fisher Tobi,Jabbour Elias,Cortés Jorge E.,Kantarjian Hagop,Anderlini Paolo,Alousi Amin,Hosing Chitra,Shpall Elizabeth,Popat Uday,Qazilbash Muzaffar,Andersson Borje,Giralt Sergio

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference56 articles.

1. Allogeneic bone marrow transplantation for chronic myelogenous leukemia;Champlin,1994

2. Allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic or accelerated phase;Champlin;Blood,1982

3. Chronic myeloid leukemia: current treatment options;Goldman;Blood,2001

4. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia;Hansen;N Engl J Med,1998

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic haematopoietic stem cell transplantation with reduced-intensity conditioning in chronic myeloid leukaemia;Russian journal of hematology and transfusiology;2020-12-10

2. All is not lost in accelerated phase/blast crisis and after tyrosine kinase inhibitors fail in chronic myeloid leukaemia: a retrospective study of allogeneic stem cell transplant outcomes in Australia and New Zealand;Bone Marrow Transplantation;2016-05-23

3. Janus Kinase Inhibitors and Stem Cell Transplantation in Myelofibrosis;Clinical Lymphoma Myeloma and Leukemia;2015-06

4. Passé et futur de la LMC: allogreffe de CSH, omacetaxine et ponatinib;Oncologie;2012-10

5. Bcr–Abl dependent post-transcriptional activation of NME2 expression is a specific and common feature of chronic myeloid leukemia;Leukemia & Lymphoma;2012-03